Gene-Modified T Cells, Vaccine Therapy, and Ipilimumab in Treating Patients With Locally Advanced or Metastatic Malignancies
Clinical trial NCT02070406 · TERMINATED
Trial details
- NCT number
- NCT02070406
- Sponsor
- Jonsson Comprehensive Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-17
- Primary completion
- 2018-12-18
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.